Maryland racing stakeholders and regulators have scheduled an online community forum to discuss and answer questions regarding the Maryland Racing Commission’s action to remove testing thresholds for five corticosteroids.
The Zoom webinar meeting will take place on Tuesday, September 28 at noon EST.
Participants include CRM Executive Director Mike Hopkins; MRC member Dr. Thomas Bowman, who chairs the commission’s Equine Safety, Health and Welfare Advisory Committee; Dr. Dionne Benson, Chief Veterinarian for 1/ST RACING (The Stronach Group); Dr. Mary Scollay, Executive Director of the Racing Medication and Testing Consortium and Alan Foreman, General Counsel of the Maryland Thoroughbred Horsemen’s Association and General Manager of the THA.
The MRC, on the recommendation of the advisory committee chaired by Bowman, approved a motion to amend a regulation on the five corticosteroids to eliminate test thresholds and employ the limit of detection – the lowest level at which a laboratory can confidently detect a substance in a sample.
The change will be filed with emergency status and there will be a public comment period. The updated regulations are expected to be implemented Nov. 1, Hopkins said.
The five corticosteroids are dexamethasone, prednisolone, betamethasone, isoflupredone and triamcinolone. The current 14-day waiting period for intra-articular injections will remain in place under the 2019 model rules approved by the Association of Racing Commissioners International and CCDR.
The advisory committee discussed the proposal at a meeting on September 8 following several positive dexamethasone results and reports that the corticosteroid was routinely given by some vets 48 hours before a race at a lower dose rather than the CCDR recommended 72 hour withdrawal. time at the usual dose.
The webinar is open to all Maryland equestrians and practicing veterinarians. Prior registration is required to join by clicking here.